C18orf32 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
macrophage	12 studies	20% ± 3%	Explore
plasmacytoid dendritic cell	10 studies	30% ± 8%	Explore
non-classical monocyte	9 studies	31% ± 13%	Explore
classical monocyte	8 studies	23% ± 6%	Explore
natural killer cell	8 studies	21% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	22% ± 4%	Explore
regulatory T cell	8 studies	21% ± 2%	Explore
fibroblast	8 studies	20% ± 4%	Explore
naive B cell	7 studies	20% ± 4%	Explore
CD8-positive, alpha-beta T cell	7 studies	19% ± 4%	Explore
mucosal invariant T cell	7 studies	22% ± 4%	Explore
gamma-delta T cell	7 studies	21% ± 4%	Explore
mature NK T cell	7 studies	21% ± 4%	Explore
CD4-positive, alpha-beta T cell	6 studies	17% ± 1%	Explore
memory B cell	6 studies	18% ± 3%	Explore
endothelial cell	6 studies	20% ± 2%	Explore
smooth muscle cell	6 studies	24% ± 6%	Explore
B cell	6 studies	20% ± 4%	Explore
conventional dendritic cell	6 studies	30% ± 11%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	19% ± 4%	Explore
dendritic cell	5 studies	21% ± 6%	Explore
pericyte	5 studies	23% ± 5%	Explore
retinal cone cell	5 studies	28% ± 7%	Explore
ciliated cell	5 studies	33% ± 11%	Explore
epithelial cell of proximal tubule	4 studies	24% ± 8%	Explore
kidney loop of Henle epithelial cell	4 studies	34% ± 8%	Explore
epithelial cell	4 studies	31% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	18% ± 1%	Explore
retina horizontal cell	4 studies	26% ± 7%	Explore
retinal rod cell	4 studies	22% ± 6%	Explore
mast cell	4 studies	27% ± 1%	Explore
CD4-positive, alpha-beta memory T cell	4 studies	19% ± 3%	Explore
plasma cell	3 studies	26% ± 10%	Explore
effector CD8-positive, alpha-beta T cell	3 studies	20% ± 4%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	3 studies	18% ± 4%	Explore
retinal ganglion cell	3 studies	52% ± 25%	Explore
myeloid cell	3 studies	19% ± 3%	Explore
monocyte	3 studies	26% ± 7%	Explore
ON-bipolar cell	3 studies	43% ± 36%	Explore
rod bipolar cell	3 studies	37% ± 19%	Explore
T follicular helper cell	3 studies	20% ± 3%	Explore
intermediate monocyte	3 studies	16% ± 0%	Explore
neuron	3 studies	37% ± 8%	Explore
astrocyte	3 studies	26% ± 6%	Explore
abnormal cell	3 studies	26% ± 12%	Explore
CD8-positive, alpha-beta memory T cell	3 studies	26% ± 7%	Explore
endothelial cell of lymphatic vessel	3 studies	21% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	18% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	20% ± 3%	Explore
oligodendrocyte	3 studies	21% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	5 studies	21% ± 5%	Explore
eye	4 studies	26% ± 9%	Explore
kidney	3 studies	26% ± 10%	Explore
lung	3 studies	19% ± 2%	Explore
uterus	3 studies	18% ± 1%	Explore
brain	3 studies	25% ± 2%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	100%	7574.32	2642 / 2642	100%	5.26	703 / 705
thymus	100%	2878.14	652 / 653	95%	2.71	575 / 605
prostate	100%	2549.26	245 / 245	93%	2.02	468 / 502
breast	100%	2425.98	459 / 459	89%	2.30	999 / 1118
kidney	100%	3862.26	89 / 89	89%	2.40	799 / 901
adrenal gland	100%	3739.54	258 / 258	86%	3.06	198 / 230
ovary	100%	2471.52	180 / 180	80%	1.75	346 / 430
stomach	100%	2548.57	359 / 359	80%	1.51	228 / 286
pancreas	99%	1717.93	325 / 328	80%	1.64	143 / 178
intestine	100%	2611.39	966 / 966	76%	1.44	403 / 527
lung	99%	2780.32	574 / 578	74%	1.43	850 / 1155
bladder	100%	2378.19	21 / 21	68%	1.35	342 / 504
skin	99%	1629.83	1786 / 1809	69%	1.40	324 / 472
esophagus	100%	2186.10	1445 / 1445	66%	1.26	121 / 183
uterus	100%	2238.81	170 / 170	65%	1.29	300 / 459
liver	100%	2538.92	226 / 226	41%	0.74	167 / 406
spleen	100%	2378.30	241 / 241	0%	0	0 / 0
adipose	100%	2399.42	1202 / 1204	0%	0	0 / 0
blood vessel	100%	2835.14	1330 / 1335	0%	0	0 / 0
heart	96%	2123.51	825 / 861	0%	0	0 / 0
muscle	94%	1169.39	756 / 803	0%	0	0 / 0
peripheral blood	83%	1663.05	770 / 929	0%	0	0 / 0
lymph node	0%	0	0 / 0	79%	1.41	23 / 29
eye	0%	0	0 / 0	73%	1.54	58 / 80
tonsil	0%	0	0 / 0	69%	1.40	31 / 45
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0043123	Biological process	positive regulation of canonical NF-kappaB signal transduction
GO_0005783	Cellular component	endoplasmic reticulum
GO_0005811	Cellular component	lipid droplet
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	C18orf32
Protein name	UPF0729 protein C18orf32 (Putative NF-kappa-B-activating protein 200)
Synonyms
Description	FUNCTION: May activate the NF-kappa-B signaling pathway. .
Accessions	ENST00000613385.4 Q8TCD1 ENST00000582392.2 ENST00000318240.8

C18orf32 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review